Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
2020
Interest is growing in the role of pituitary adenylate cyclase-activating polypeptide (PACAP) and its specific PAC1 receptor in migraine and in their antagonism as a strategy for migraine preventio...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
70
References
7
Citations
NaN
KQI